Monica Gallego

Dr. Monica Gallego

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2007 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
PDF file
MGMonica Gallego
Monica Gallego
DVDavid M. Virshup
David M. Virshup

1 April 2008 in Neuron
Verified
Journal Article
Closed access
QMQing-Jun Meng
Qing-Jun Meng
LLLarisa Logunova
Larisa Logunova
EMElizabeth S. Maywood
Elizabeth S. Maywood
MGMonica Gallego
Monica Gallego
JLJake Lebiecki
Jake Lebiecki
ALAndrew S.I. Loudon
Andrew S.I. Loudon

11 July 2006 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MGMonica Gallego
Monica Gallego
EEErik J. Eide
Erik J. Eide
MWMargaret F. Woolf
Margaret F. Woolf
DVDavid M. Virshup
David M. Virshup
DFDaniel B. Forger
Daniel B. Forger
Biological clocks with a period of ≈24 h (circadian) exist in most organisms and time a variety of functions, including sleep–wake cycles, hormone release, bioluminescence, and core body temperature fluctuations. Much of our understanding of the clock mechanism comes from the identification of specific mutations that affect circadian behavior. A widely studied mutation in casein kinase I (CKI), the CKIε tau mutant, has been shown to cause a loss of kinase function in vitro , but it has been difficult to reconcile this loss of function with the current model of circadian clock function. Here we show that mathematical modeling predicts the opposite, that the kinase mutant CKIε tau increases kinase activity, and we verify this prediction experimentally. CKIε tau is a highly specific gain-of-function mutation that increases the in vivo phosphorylation and degradation of the circadian regulators PER1 and PER2. These findings experimentally validate a mathematical modeling approach to a complex biological function, clarify the role of CKI in the clock, and demonstrate that a specific mutation can be both a gain and a loss of function depending on the substrate.

1 April 2005 in Current Opinion in Cell Biology
Verified
Journal Article
Closed access
MGMonica Gallego
Monica Gallego
DVDavid M Virshup
David M Virshup

1 January 2007 in Cold Spring Harbor Symposia on Quantitative Biology
Verified
Journal Article
Open access
PDF file
DVD. M. Virshup
D. M. Virshup
EEE. J. Eide
E. J. Eide
DFD. B. Forger
D. B. Forger
MGMonica Gallego
Monica Gallego
EHE. Vielhaber Harnish
E. Vielhaber Harnish
Protein phosphorylation regulates the period of the circadian clock within mammalian cells. Circadian rhythms are an approximately 24-hour cycle that regulates key biological processes. Daily fluctuations of wakefulness, stress hormones, lipid metabolism, immune function, and the cell division cycle are controlled by the molecular clocks that function throughout our bodies. Mutations in regulatory components of the clock can shorten or lengthen the timing of the rhythms and have significant physiological consequences. The clock is formed by a negative feedback loop of transcription, translation, and inhibition of transcription. The precision of clock timing is controlled by protein kinases and phosphatases. Casein kinase Iϵ is a protein kinase that regulates the circadian clock by periodic phosphorylation of the proteins PER1 and PER2, controlling their stability and localization. The role of phosphorylation in regulating PER function in the clock has been explored in detail. Quantitative modeling has proven to be very useful in making important predictions about how changes in phosphorylation alter the clock's behavior. Quantitative data from biological studies can be used to refine the quantitative model and make additional testable predictions. A detailed understanding of how reversible protein phosphorylation regulates circadian rhythms and a detailed quantitative model that makes clear, testable, and accurate predictions about the clock and how we may manipulate it can have important benefits for human health. Pharmacological manipulation of rhythms could mitigate stress from jet lag, shift work, and perhaps even seasonal affective disorder.

13 September 2006 in Biochemical Journal
Verified
Journal Article
Closed access
MGMonica Gallego
Monica Gallego
HKHeeseog Kang
Heeseog Kang
DVDavid M. Virshup
David M. Virshup
The circadian clock is regulated by a transcription/translation negative feedback loop. A key negative regulator of circadian rhythm in mammals is the PER2 (mammalian PERIOD 2) protein. Its daily degradation at the end of the night accompanies de-repression of transcription. CKIϵ (casein kinase I ϵ) has been identified as the kinase that phosphorylates PER2, targeting it for ubiquitin-mediated proteasomal degradation. We now report that PER2 degradation is also negatively regulated by PP1 (protein phosphatase 1)-mediated dephosphorylation. In Xenopus egg extract, PP1 inhibition by Inhibitor-2 accelerated mPER2 degradation. Co-immunoprecipitation experiments showed that PER2 bound to PP1c in transfected HEK-293 cells. PP1 immunoprecipitated from HEK-293 cells, mouse liver and mouse brain, dephosphorylated CKIϵ-phosphorylated PER2, showing that PER2 is a substrate for mammalian endogenous PP1. Moreover, over-expression of the dominant negative form of PP1c, the D95N mutant, accelerated ubiquitin and proteasome-mediated degradation of PER2, and shortened the PER2 half-life in HEK-293 cells. Over-expression of the PP1 inhibitors, protein phosphatase 1 holoenzyme inhibitor-1 and Inhibitor-2, confirmed these results. Thus PP1 regulates PER2 stability and is therefore a candidate to regulate mammalian circadian rhythms.